Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Osteoactivin/GPNMB Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF2330SP
This item is not returnable.
View return policy
Description
Osteoactivin/GPNMB Polyclonal specifically detects Osteoactivin/GPNMB in Mouse samples. It is validated for Western Blot, Neutralization, ELISA Capture (Matched Antibody Pair).Specifications
Osteoactivin/GPNMB | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
DC-HIL, glycoprotein (transmembrane) nmb, glycoprotein NMB, GPNMB, HGFIN, HGFINglycoprotein nmb-like protein, NMBosteoactivin, Transmembrane glycoprotein HGFIN, transmembrane glycoprotein NMB | |
Goat | |
Affinity Purified | |
RUO | |
10457 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Neutralization, ELISA | |
LYOPH | |
Western Blot 0.1 ug/mL, Neutralization 0.2-0.8 ug/mL, ELISA Capture (Matched Antibody Pair) 0.2-0.8 ug/mL | |
Q8BVA0 | |
GPNMB | |
Mouse myeloma cell line NS0-derived recombinant mouse Osteoactivin/GPNMB Lys23-Asn502 Accession # Q8BVA0 | |
25 μg | |
Primary | |
Detects mouse Osteoactivin/GPNMB in ELISAs and Western blots. In sandwich immunoassays, less than 0.2% cross-reactivity with recombinant human (rh) Osteoactivin, rhSyndecan-4, and recombinant mouse Syndecan-4 is observed. | |
Mouse | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction